Table 3.
Patient outcomes.
| Features | First Period | Second Period |
|---|---|---|
| Total postoperative adverse events: n (%) | 50 (30) | 326 (30.3) |
| Minor postoperative adverse events: n (%) | 30 (18) | 192 (17.8) |
| Major postoperative adverse events: n (%) ** | 20 (12) | 134 (12.4) |
| Pneumonia | 9 | 45 |
| Atelectasis requiring bronchoscopy | 2 | 5 |
| Acute respiratory distress syndrome | 0 | 14 |
| Invasive mechanical ventilation > 24 h | 1 | 20 |
| Acute pulmonary edema | 1 | 2 |
| Pulmonary embolism | 1 | 3 |
| Myocardial infarction | 0 | 2 |
| Cardiac failure | 0 | 1 |
| Arhythmia | 4 | 10 |
| Neurological complications (stroke) | 0 | 1 |
| Acute renal failure | 2 | 5 |
| Deep vein thrombosis | 0 | 1 |
| Hemothorax | 5 | 23 |
| Chylothorax | 1 | 2 |
| Postoperative length of stay (day): median (IQR) | 6 (5 to 8) | 6 (5 to 9) |
| Patients back home after hospitalization: n (%) | 139 (84) | 991 (81) |
** Some patients have had >1 postoperative events.